AI Summary
We reviewed 58 live results for infliximab infusion and narrowed them down to the 3 options that look most worth comparing first.
The strongest themes across this short list are Rheumatology and Medicine.
Comparison Table
Recommended
Infliximab Infusion
Source: Samitivej Hospital
Description
A biologic DMARD (TNF inhibitor) administered as an intravenous infusion (100 mg sterile powder). This service is typically provided in a hospital setting for patients with rheumatoid arthritis requiring intensive biologic therapy.
Best for
intravenous infusion therapy, biologic DMARD treatment, TNF inhibitor access and hospital-based medical care
View Details
Rating
Actemra Intravenous (IV) Infusion
Source: Roche
Description
Actemra is an Interleukin-6 (IL-6) receptor antagonist containing the active ingredient tocilizumab. This intravenous formulation is used for treating moderate to severe active Rheumatoid Arthritis (RA), Polyarticular Juvenile Idiopathic Arthritis (pJIA), and Systemic Juvenile Idiopathic Arthritis (sJIA). In Thailand, it is available in 80 mg, 200 mg, and 400 mg vials (20 mg/mL), distributed through DKSH. It is a critical biologic therapy for controlling systemic inflammation and joint damage.
Best for
Rheumatoid arthritis management, Juvenile idiopathic arthritis, Hospital-based IV treatment and Thai local access
View Details
Rating
Remsima (Infliximab)
Source: Celltrion Healthcare Philippines Inc.
Description
Remsima is a biosimilar for treating autoimmune diseases such as Crohn’s disease and Rheumatoid Arthritis.
Best for
Crohn’s disease patients, Rheumatoid Arthritis and autoimmune disease management
View Details
Rating
| Compare | Infliximab Infusion | Actemra Intravenous (IV) Infusion | Remsima (Infliximab) |
|---|---|---|---|
| Source | Samitivej Hospital | Roche | Celltrion Healthcare Philippines Inc. |
| Description | A biologic DMARD (TNF inhibitor) administered as an intravenous infusion (100 mg sterile powder). This service is typically provided in a hospital setting for patients with rheumatoid arthritis requiring intensive biologic therapy. | Actemra is an Interleukin-6 (IL-6) receptor antagonist containing the active ingredient tocilizumab. This intravenous formulation is used for treating moderate to severe active Rheumatoid Arthritis (RA), Polyarticular Juvenile Idiopathic Arthritis (pJIA), and Systemic Juvenile Idiopathic Arthritis (sJIA). In Thailand, it is available in 80 mg, 200 mg, and 400 mg vials (20 mg/mL), distributed through DKSH. It is a critical biologic therapy for controlling systemic inflammation and joint damage. | Remsima is a biosimilar for treating autoimmune diseases such as Crohn’s disease and Rheumatoid Arthritis. |
| Best for | intravenous infusion therapy, biologic DMARD treatment, TNF inhibitor access and hospital-based medical care | Rheumatoid arthritis management, Juvenile idiopathic arthritis, Hospital-based IV treatment and Thai local access | Crohn’s disease patients, Rheumatoid Arthritis and autoimmune disease management |
| Tags | |||
| Action | View Details | View Details | View Details |
| Rating |
AI Recommendation
If you want the most balanced option to start with, I recommend:
"Infliximab Infusion from Samitivej Hospital."
I picked this because Ideal for patients requiring hospital-monitored biologic infusion therapy for rheumatoid arthritis management.
Share this search
Related Finds